❌

Normal view

Brewing up Europe’s competitiveness

16 November 2026 at 05:00

As Europe steps up the implementation of its One Europe, One Market agenda, attention is turning to how its competitiveness ambitions can translate into investment and growth. Founded in Amsterdam in 1864, Heineken has become Europe’s leading brewer, supporting a value chain stretching from farmers and bottle makers to local pubs and restaurants. Following the November 4 Beyond the Glass: Brewing Local Competitiveness event in Brussels, Heineken’s president of Europe, Glenn Caton, reflects on how policymakers and businesses can work together to sustain investment, and why the practical experience of suppliers, hospitality entrepreneurs and other partners should help shape European policymaking.

Glenn Caton, President of Europe, Heineken

Heineken has been brewing in Europe for more than 160 years. What has made it such a good place to do business?
”Europe has an enormous amount going for it. We’ve got fantastic talent, world-class universities, strong institutions and an industrial base built up over generations. And of course, there’s the single market, which is a tremendous advantage for businesses operating across Europe.

Heineken started brewing here when beer was still delivered by horse-drawn carts, and Europe has been our home ever since. We still brew close to our consumers and work with local customers and suppliers, some through relationships going back generations. They know our business, we know theirs, and that helps us keep improving and innovating together.”

You’ve mentioned innovation. Brewing is one of Europe’s oldest industries. What does innovation look like at Heineken today?
“As you said, beer has been part of European life for a very long time. But that doesn’t mean the way we make it has stood still. There’s an enormous amount of science and technology behind brewing today, from developing new products to making production more efficient and reducing our environmental footprint.

One of our key areas of innovation is alcohol-free beer. We’ve invested a great deal in improving the taste and quality of 0.0 beer, as well as finding new ways for people to enjoy it. We know that when Heineken® 0.0 is available on draught in bars, significantly more consumers choose it as a natural part of their out-of-home experience. That’s why we’re delighted that it’s now available on draught in 10,000 outlets across Europe.

Heineken started brewing here when beer was still delivered by horse-drawn carts, and Europe has been our home ever since.

We’ve also invested €45 million in our global R&D center in the Netherlands, which opened in 2025. It brings together specialists from 12 countries, combining their expertize to develop the next generation of brewing innovations. The center is close to Delft University of Technology, where we have a dedicated Heineken laboratory and collaborate on biotechnology and fermentation research.

We’re pioneering new technologies to lessen our usage of natural gas as we decarbonize our operations, whether that is solar thermal and biogas solutions in our Spanish breweries, which now run on 100% renewable energy, or our heat battery project in Portugal, which will go live in 2027. This innovation doesn’t happen in isolation. We work with equipment manufacturers, technology companies and researchers to turn new ideas into products and experiences people enjoy every day. For me, that’s one of Europe’s great strengths: bringing together industrial expertize, research and talent to make innovation happen.”

And how does Heineken contribute to the wider European economy?
“Just look at what goes into a glass of beer: farmers growing barley, businesses making bottles and equipment, transport companies delivering the beer, and the cafés, pubs and restaurants serving our products. It’s a huge eco-system, much of it made up of family businesses rooted in their communities.

Source: Heineken

Our activity supports close to 430,000 jobs across the value chain and around €34 billion in GDP contributions. In 2025, we purchased around €9 billion in goods and services from European suppliers. And because 98% of the inputs used by our European operating companies are sourced within Europe, much of that value stays within the European economy.”

Recent FoodDrinkEurope research suggests that Europe’s attractiveness as an investment destination is under pressure. What will it take to keep businesses investing here?
“We spend a lot of time talking about which new industries Europe needs to attract, and rightly so. But we should pay just as much attention to what it takes for established businesses to keep investing here.

I’m a farmer’s son from Yorkshire, so I grew up understanding long-term investment. Farming families think in generations, and I see that same long-term mindset at Heineken. In 2025 alone, we invested more than €500 million in our European production sites. Investments like these depend on access to talent, competitive costs and clear, predictable rules.

For me, that’s one of Europe’s great strengths: bringing together industrial expertize, research and talent to make innovation happen.

Packaging is a good example. We’ve invested for years in reusable systems, from beer kegs to returnable bottles and crates. We absolutely support Europe’s ambition to make packaging more sustainable. But when businesses are making long-term investments, clarity matters. We need realistic timelines, clear guidance and rules that recognize systems that are already working well.

The same applies to proposals on territorial supply constraints. We understand the objective, but any new rules need to work for businesses like ours that are decentralized and produce close to local consumers. We should be removing barriers to growth and investment across the single market, not inadvertently creating new ones.

And the same is true of the energy transition. Decarbonizing an industrial business requires significant long-term investment. Projects like those we’re pioneering in Spain and Portugal show what’s possible, but scaling these technologies will require businesses, governments and energy partners to work together. The investment conditions have to support that.”

Beyond its economic contribution, what role does the brewing industry play in European communities?
“One of the things I love about Europe is its hospitality and bar culture. Whether you’re in a Dutch brown café, a Spanish taverna, a French café or here in Brussels on Place Luxembourg, these are places where people meet, talk and spend time together. They are third spaces. In a world where so much happens through screens, I think that role matters more than ever.

And their economic contribution matters too. Across Europe, our activities support 186,400 jobs in hotels, restaurants and cafés, contributing €6.4 billion to the region’s GDP. Hospitality is also closely linked to tourism. Tourists spend close to €2.5 billion on Heineken beers in Europe each year, much of it through hospitality venues. So when we talk about keeping Europe’s hospitality sector vibrant, we’re talking about local jobs, tourism and the social fabric of communities as well.”

What would you like European policymakers to take away from this conversation?
“Europe has some fantastic businesses, and we shouldn’t take for granted what they can continue to contribute to our economy. We need new industries and technologies, absolutely. But we also need the right conditions for established businesses and their partners across the value chain to keep investing and growing.

The Brussels event reinforced something quite simple for me: policymaking works better when there’s an open dialogue. At Heineken, we want to be a constructive partner, bringing not just our own experience but what we hear from farmers, suppliers and hospitality entrepreneurs across our value chain. Ultimately, we share the same ambition: a Europe that is competitive, sustainable and remains a place where businesses want to make their next investment.”


Disclaimer

POLITICAL ADVERTISEMENT

  • The sponsor is Heineken.
  • The advertisement relates to EU competitiveness and Single Market policy and advocates for predictable, proportionate regulation and investment conditions that support established businesses and economic growth in Europe.

More information here.

Europe’s moment to lead: Backing research in a global race

16 November 2026 at 05:00

Europe’s population is aging, with an increased burden of chronic diseases: more than half of adults in the European Union are now overweight and one in six is obese.1 In parallel, we are exposed to new threats from biosecurity, the malicious use of artificial intelligence, climate-related health threats and drug-resistant superbugs.

We are not passive bystanders. European teachers, biologists, nurses and manufacturers have all played a role in developing innovations that protect our populations and help them thrive. Now is not the time to step back. We believe health research and innovation are economic drivers of Europe’s future, not discretionary costs. Backing research in health as a pillar of our future in a global race is the right choice. It enables Europe to lead and support sustainable growth, as a pillar of the new architecture of global health.

We believe health research and innovation are economic drivers of Europe’s future, not discretionary costs.

The evidence is all around us. A vaccine developed against tuberculosis has been a frontline bladder cancer treatment for over 40 years,2 technology first developed for a malaria vaccine now helps protect millions against shingles,3 and mRNA research, developed over decades, enabled Europe’s fastest-ever vaccine response to Covid-19.4 Scientific progress rarely remains confined to the place or problem where it begins.

Public budgets are under pressure, but these achievements show what investment in global health research can deliver. Pressure can be a catalyst, focusing minds, sharpening priorities and turning constraints into innovative breakthroughs. Too often, the debate is framed in terms of what Europe gives. Too rarely is it framed in terms of what Europe and its people receive in return. With commitment, we can find pragmatic ways to maximize our investments as a union.

Building on its strengths in life sciences, Europe can advance its health sovereignty and seize the emerging opportunities in scientific discovery, next-generation vaccines and biomanufacturing. Basic and applied research become new technologies, intellectual property, skilled jobs and revenues that protect European health, growth and wealth. Together, these returns are Europe’s Health Dividend.

Europe’s health, security and prosperity depend on its ability to contribute to, and benefit from, global networks of research and innovation. Retreating from global research would not reduce vulnerability; it would increase it. Investing and engaging beyond our borders is a strategic imperative for Europe.

Retreating from global research would not reduce vulnerability; it would increase it. Investing and engaging beyond our borders is a strategic imperative for Europe.

At a time when public investment must deliver its value, we can find ways to maximize the impact of European money by working and funding a shared agenda together, not as disjointed nations. Health research remains one of the clearest examples of an investment that strengthens Europe’s future while delivering benefits today.

Back Europe’s Health Dividend. Sign the declaration.

SIGNATORIES

Europe’s Health Dividend is funded by the Gates Foundation and Coefficient Giving.


References

  1. Eurostat. Over half of adults in the EU are overweight. 4 September 2026. https://ec.europa.eu/eurostat/web/products-eurostat-news/w/ddn-20260904-1
  2. Kluemper A, Morris K, Mellon MJ. From plague to the promise: The journey of Bacille Calmette–Guérin. Bladder. 2024;11(4):e21200022. https://doi.org/10.14440/bladder.2024.0035
  3. Impact Global Health. From malaria research to protecting aging populations: AS01 Adjuvant in Shingrix. https://www.impactglobalhealth.org/insights/report-library/shingrix-vaccine
  4. European Medicines Agency. EMA recommends first COVID-19 vaccine for authorisation in the EU. 21 December 2020. https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu

Disclaimer

POLITICAL ADVERTISEMENT

  • The sponsor is Europe’s Health Dividend.
  • The advertisement is linked to investment in global health research and development and its contribution to Europe’s health, security, resilience and economic competitiveness.

More information here.

❌